Needed: Information on Technology's Impact

The watchword in Washington and the rest of the United States is competitiveness. There have been more discussions by more people about America's ability (or inability) to compete internationally than perhaps about any other topic this year. And with each announcement of further erosion in the U.S. balance of payments, the intensity of that discussion escalates. The problem has been at least two decades in the making. American industry did not modernize its manufacturing processes soon enough.

Written byEugene Garfield
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The problem has been at least two decades in the making. American industry did not modernize its manufacturing processes soon enough. It did not pay enough attention to quality. It looked for high short-term re turns and neglected investments in R&D that ensure long-term prosperity. Moreover, the federal government has eschewed any thing like a coordinated industrial policy.

But now there is consensus that the federal government can and should play a role in improving America's competitive position. In his last State of the Union address, President Reagan underscored competitive ness as a priority issue for the nation and for his administration. In Congress, 160 senators and representatives have joined a caucus to promote competitiveness. Outside government, some 25 institutions in industry, education and labor have banded together as the Council on Competitiveness.

Out of all this, however, little of substance has yet emerged. In the past few years the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies